65 related articles for article (PubMed ID: 23171856)
1. Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis.
Zhong DN; Wu JZ; Li GJ
Acta Haematol; 2013; 129(2):90-5. PubMed ID: 23171856
[TBL] [Abstract][Full Text] [Related]
2. CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Such E; Cervera J; Terpos E; Bagán JV; Avaria A; Gómez I; Margaix M; Ibañez M; Luna I; Cordón L; Roig M; Sanz MA; Dimopoulos MA; de la Rubia J
Haematologica; 2011 Oct; 96(10):1557-9. PubMed ID: 21685474
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.
Katz J; Gong Y; Salmasinia D; Hou W; Burkley B; Ferreira P; Casanova O; Langaee TY; Moreb JS
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):605-11. PubMed ID: 21396799
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
Sarasquete ME; García-Sanz R; Marín L; Alcoceba M; Chillón MC; Balanzategui A; Santamaria C; Rosiñol L; de la Rubia J; Hernandez MT; Garcia-Navarro I; Lahuerta JJ; González M; San Miguel JF
Blood; 2008 Oct; 112(7):2709-12. PubMed ID: 18594024
[TBL] [Abstract][Full Text] [Related]
5. New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.
Balla B; Vaszilko M; Kósa JP; Podani J; Takács I; Tóbiás B; Nagy Z; Lazáry A; Lakatos P
Oral Dis; 2012 Sep; 18(6):580-5. PubMed ID: 22339777
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
Guo Z; Cui W; Que L; Li C; Tang X; Liu J
Int J Oral Maxillofac Surg; 2020 Mar; 49(3):298-309. PubMed ID: 31445964
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.
Arduino PG; Menegatti E; Scoletta M; Battaglio C; Mozzati M; Chiecchio A; Berardi D; Vandone AM; Donadio M; Gandolfo S; Scully C; Broccoletti R
J Oral Pathol Med; 2011 Jul; 40(6):510-5. PubMed ID: 21251073
[TBL] [Abstract][Full Text] [Related]
9. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
[TBL] [Abstract][Full Text] [Related]
10. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.
Kastritis E; Melea P; Bagratuni T; Melakopoulos I; Gavriatopoulou M; Roussou M; Migkou M; Eleutherakis-Papaiakovou E; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2017 Oct; 58(10):2304-2309. PubMed ID: 28604257
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
Fortuna G; Ruoppo E; Pollio A; Aria M; Adamo D; Leuci S; Orabona GD; Mignogna MD
J Oral Pathol Med; 2012 Mar; 41(3):222-8. PubMed ID: 22092390
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
Pechalova P; Bakardjiev A; Zaprianov Z; Vladimirov B; Poriazova E; Zheleva A; Hadjigeorgiev G; Goranova-Marinova V; Goranov S
Acta Clin Croat; 2011 Jun; 50(2):273-9. PubMed ID: 22263396
[TBL] [Abstract][Full Text] [Related]
15. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
17. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.
Blanco G; Martínez C; Ladero JM; Garcia-Martin E; Taxonera C; Gamito FG; Diaz-Rubio M; Agundez JA
Pharmacogenet Genomics; 2008 Jan; 18(1):37-43. PubMed ID: 18216720
[TBL] [Abstract][Full Text] [Related]
19. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
20. HTRA1 promoter polymorphism and risk of age-related macular degeneration: a meta-analysis.
Tang NP; Zhou B; Wang B; Yu RB
Ann Epidemiol; 2009 Oct; 19(10):740-5. PubMed ID: 19375943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
